InterCure Schedules Third Quarter 2021 Financial Results Conference Call
November 11, 2021 08:00 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 11, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that...
InterCure Announces Record Preliminary Third Quarter Revenue of CAD$24 million - 3 Times YOY and 36% QOQ Growth
October 25, 2021 01:30 ET
|
InterCure Ltd.
Achieved a number of firsts and records including: Seventh consecutive quarter of double-digit revenue growth Seventh consecutive quarter of high digit accelerated profitable growth Record...
InterCure to Present in Benzinga Cannabis Capital Conference
October 13, 2021 12:15 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that...
InterCure CEO Alex Rabinovitch Purchases Over 420,000 Shares of Company Stock in The Open Market
October 12, 2021 02:00 ET
|
InterCure Ltd.
NEW YORK, TORONTO and HERZLIYA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that...
InterCure Re-Announces its Record-Breaking Second Quarter Financial Results With 4 Times YOY Revenue Growth - Following NASDAQ Listing
September 03, 2021 09:29 ET
|
InterCure Ltd.
Achieved record revenue of NIS 45 million (over CAD$17 million), an increase of 400% year-over-year and 37% quarter-over-quarter Achieved quarterly run-rate Q2 Pro Forma1 revenues of NIS 55 million...
InterCure Continuing its Medical Cannabis Consolidation Strategy, Announces Strategic Acquisition of Cannomed Pharmacy Chain
September 02, 2021 09:39 ET
|
InterCure Ltd.
Acquisition includes two medical cannabis dispensing pharmacies, another pharmacy in the process of receiving its license and a medical cannabis patient support center Companies will partner in...
InterCure Commences Trading on NASDAQ Under the Symbol “INCR”
September 01, 2021 01:00 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Sept. 01, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (the “Company”) is pleased to announce the...
InterCure Advances Towards NASDAQ Listing
July 19, 2021 09:36 ET
|
InterCure Ltd.
TORONTO, July 19, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (TSX: INCR.U, TASE: INCR)(dba Canndoc)(the “Company”) is pleased to announce that further to its confidential filing with the U.S....
InterCure provides an Update on its NASDAQ Listing
July 10, 2021 16:54 ET
|
InterCure Ltd.
TORONTO and HERZLIYA, Israel, July 10, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (TSX: INCR.U, TASE: INCR)(dba Canndoc)(the “Company”) is pleased to announce that further to its confidential filing...
InterCure Acquires One of Israel's Leading Active Medical Cannabis Trade Houses & Initiates Special Home Delivery Service in Collaboration With UPS
May 20, 2021 06:46 ET
|
InterCure Ltd.
Acquisition of one of the leading active, IMCA approved trade houses in Israel expanding InterCure's sales channel, distribution, delivery and storage capacity. As part of the acquisition, two...